Deep Longevity Selected by Kickstart as One of the Most Promising Start-ups in the World Discussing Proof of Concepts with Big Insurance and Health and Wellbeing Companies

Deep Longevity Published and Granted the First Microbiomic Aging Clock Patent

Deep Longevity Announces Latest Operational Update

Operational Update on the PE Prevention Drug Fortacin / Senstend - Phase 3 Study in China is Estimated to Complete in November 2022

Deep Longevity Launched a Free Self-help Application, FuturSelf, Powered by Research Conducted with Harvard Medical School, on Optimizing Future Well-being with Artificial Intelligence